Users Discontinuing Slimming Jabs Regain Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

Fresh analysis reveals that people who stop using new GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who stop traditional lifestyle regimens.

Published data in a leading medical journal points out that while overweight individuals can lose a large proportion of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month after stopping.

"Individuals using these medications should be informed of the potential of rapid weight regain when the medication ends," cautioned expert Dr. Susan Jebb.

Such speed of recovery implies a return to original mass in about a year and a half.

Comparing Treatments

The analysis, which looked at dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with older methods.

The team emphasize that people who lose weight through diet and exercise typically experience a less rapid creep back—around 100 grams monthly—post-intervention.

Understanding the Rapid Rebound

Doctors suggest the mechanism of the injections accounts for the accelerated weight return.

These medications imitate a natural hormone called GLP-1, which helps regulate appetite.

"Artificially providing GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this medication results in appetite is no longer kept in check, making overeating a significant risk."

A Lifelong Issue?

Health authorities suggest the jabs for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.

Many experts say that, given the significant potential of relapse, the treatment is often long-term.

This perspective is reinforced by drug manufacturers, who note that the findings "underscore the persistent character of obesity," similar to managing conditions like high blood pressure.

Patient Accounts

Users who have discontinued the medication report a intense resurgence of hunger.

"It felt as if a switch activating and I was suddenly starving," said a patient.

This challenge is worsened if users have not established lasting lifestyle or habit modifications during therapy.

Significant Interest

Figures suggest that millions of people in the UK have used these injections in the last 12 months, with interest being substantial.

• Adoption is more common among women compared to males.
• The middle-aged demographic shows the highest level of interest.
• A large proportion obtain the drugs through private prescriptions rather than the NHS.

Ultimately, experts caution that while the jabs are effective agents for weight loss, they are not a magic fix and long-term success hinges on integrated lifestyle support.